UKTV Ventures
UKTV Ventures operates as a media-for-equity investment fund, backed by the television broadcaster UKTV. Their core strategy involves providing premium advertising inventory on UKTV's diverse portfolio of channels (U&Dave, U&W, U&Gold, and others) in exchange for minority equity stakes in direct-to-consumer (DTC) startups. This approach allows the startups to rapidly scale their brand awareness and customer acquisition through TV advertising, while UKTV Ventures gains equity in potentially high-growth businesses. The fund's objective is to help these companies establish themselves as recognizable brand names within the UK market. The investment proposition is tailored to companies that are ready to leverage television advertising to accelerate their growth. By foregoing traditional cash investment, UKTV Ventures provides a unique value proposition, unlocking access to a broad audience through targeted advertising campaigns. The fund aims to identify companies with a strong product-market fit and the potential to become household names, enabling them to significantly expand their customer base and market presence.
Unilever Ventures
Unilever Ventures is the venture and growth capital arm of Unilever, focusing on supporting forward-thinking founders who are building brands for the modern consumer. They aim to empower entrepreneurs with big ideas, helping them create strong brands or technology solutions that stand out and move the world forward. With over twenty years of experience, they bring expertise and leadership in the consumer goods industry, offering a unique blend of the global reach of Unilever and the agility of a skilled venture capital team. They seek to back brands of tomorrow and the technologies that enable them to succeed in large markets. Their investments span across beauty and wellness brands, commerce and enabling technologies, and B2B/enterprise technologies. They are particularly interested in emerging brands operating across both digital and physical worlds that are relatable and authentic, as well as services and technologies that enhance the consumer experience and transmute commerce. Their approach is tailored to the specific needs of consumer startups, providing access to Unilever's global network, operational expertise, and deep understanding of consumer preferences. Unilever Ventures provides a platform to help companies scale efficiently and reach a broad consumer base. By combining the resources of a corporate giant with the nimbleness of a venture capital firm, they aim to provide the "best of both worlds" to their portfolio companies. Ultimately, Unilever Ventures invests in companies that align with Unilever's broader mission of creating brands that consumers love, supporting innovation and sustainability, and driving positive change in the world. The firm offers value beyond capital, with expertise in building brands and scaling businesses.
University of East Anglia
Based on the crawled pages, it is difficult to create a comprehensive investment thesis for the University of East Anglia (UEA) as a venture capital firm. The university's website primarily focuses on providing information to prospective students, current students, and staff. The available content highlights academic programs, research, campus life, and university policies. There is no indication that the university directly operates as a VC firm with a specific investment thesis. UEA focuses on providing quality education and research opportunities, promoting employability of its graduates, and maintaining a safe and inclusive environment.
University of Strathclyde
Based on the provided information, the University of Strathclyde primarily focuses on education and research. Its investment, if any, is likely directed towards academic research initiatives, supporting students, and infrastructure development within the university itself. The university aims to provide a safe and supportive learning environment, emphasizing the importance of research in informing teaching and contributing to business, industry, and society. Their numerous accolades, including UK University of the Year, highlight their commitment to excellence and innovation within the education sector. The university also offers various scholarships and online learning programs to promote access to education. Their active engagement in research, with almost 90% rated 'world leading' or 'internationally excellent', suggests a strong focus on academic advancement and creating tangible impact through research outcomes.
Unruly Capital
Unruly Capital positions itself as a venture capital fund that operates differently, offering transparency through its public web dashboard. The firm seems to have a broad investment mandate, participating in diverse sectors such as Health, BioHealth, and Climate. They are actively deploying capital, having invested $19.6M out of a $23.9M fund across 73 investments. Their investment activity is relatively recent, indicated by the listed transactions up to January 2026. The firm publishes a manifesto that indicates a contrarian and independent spirit. Given the range of co-investors, Unruly Capital is likely willing to participate in syndicated deals with established firms. The data presented indicates an investment approach that is active and responsive to emerging opportunities. The dashboard publicly shares fund statistics, recent transactions, and visual representations of investment categories, investments per quarter, top investment locations, co-investors, and current portfolio companies. This transparency is core to their "doing things differently" approach. Given the sector information available (Climate, BioHealth, Health) and portfolio companies (Beyond Aero, Deep Science Ventures, Renaissance Fusion), it seems the fund has some inclination toward deep tech and impactful ventures. The fund's co-investors are impressive, showing that Unruly Capital is able to attract high-caliber capital allocators. Further research would be needed to flesh out all aspects of the fund's investment strategy.
West Hill Capital
West Hill Capital specializes in deploying capital into high-growth UK and international companies across diverse sectors, with a focus on financial services, biotech, cybersecurity, and fintech. The firm emphasizes aligned interests by personally investing alongside clients and leverages decades of experience in structuring high-impact transactions (e.g., IPOs, M&A, and landmark deals).
YFM Equity Partners
YFM Equity Partners provides flexible equity solutions to ambitious UK SMEs, offering growth capital (£3m–£15m) for scaling, MBO funding, and strategic support to accelerate growth. They emphasize hands-on collaboration, expertise, and a global network to help businesses scale and thrive, with a focus on sustainable, innovative strategies.
bp venture
Based on the provided crawled pages, bp ventures appears to be the venture capital arm of BP (British Petroleum). While the crawl does not contain the complete investment thesis, we can infer it revolves around creating mutual value through investments aligned with BP's strategic goals in the energy sector. The focus seems to be on companies contributing to the energy transition, sustainability, and innovative technologies relevant to BP's operations. Their approach involves a global team of venture capitalists and dealmakers, suggesting a broad scouting network. They offer a mix of financial investment and strategic partnership. They likely leverage BP's industry expertise and resources to support portfolio companies, and gain insights from disruptive technologies.
cocreatd
Cocreatd is an investment firm that focuses on building companies, not portfolios, by incubating ideas, providing funding, and offering operational support. They reject the traditional VC model, foregoing predatory terms, preference shares, and misaligned incentives. Their approach centers around co-creation, working alongside founders from the earliest stages of an idea. They provide co-founder support, aiming to increase the odds of success, and connect founders to a community of entrepreneurs, creatives, and technologists. They position themselves as more than just investors, emphasizing a long-term view and sharing risks and rewards fairly, operating as genuine co-builders from day zero. Cocreatd focuses on co-creating tech, products, and services that disrupt the status quo alongside founders who challenge conventional industry practices and outdated business models. Their investment strategy is to identify ambitious ideas and partner with founders to build companies from the ground up. They offer hands-on support, capital, and access to a likeminded founder community. They aim to radically rethink how founders are supported and how companies are designed. They seem to focus on leveraging technology to improve business processes and consumer experiences. Examples include AI scheduling assistants, AI business admin operating systems, AI search and discovery tools, and AI development resources. Their ventures aim to solve real-world problems with practical applications, providing businesses and consumers with efficiencies and new opportunities.
dmg ventures
Backs consumer startups with a focus on building mainstream brands, offering capital, discounted media credits, and marketing expertise from dmg media to reach 155M+ global consumers monthly. Combines financial investment with media leverage for rapid brand scaling.
noa (formerly A/O)
ノアハウス focuses on creating joyful and exciting home-building experiences while emphasizing sustainability through SDGs (e.g., energy efficiency, disaster resilience, and environmental conservation).
o2h Ventures
o2h Ventures focuses on seeding early-stage biotech therapeutics and related AI opportunities, particularly in the UK. The firm operates two funds: the Human Health EIS Knowledge Intensive Fund and the Human Health SEIS Fund. The EIS fund invests in companies qualifying under EIS and covering novel drug discovery along with enabling services, tools, and AI technologies. The SEIS fund targets seed-stage companies with a similar focus. o2h Ventures differentiates itself through grassroots working relationships, providing early access to deals. They aim to build a diversified portfolio of 5-10 companies and seek exits typically within 3-7 years, strategically managing exits to optimize S/EIS tax reliefs. They evaluate companies based on scientific tractability, IP position, path to the clinic, and the team's ability to navigate challenges, also attempting to gauge interest from potential acquirers early in the evaluation process. The firm actively nurtures and invests in emerging life science and tech companies, leveraging a strong pipeline of early-stage opportunities developed over 20 years of involvement in grassroots science in the UK. They operate from The Mill SciTech Park, a 2.7-acre site developed as an incubation hub for small life science companies. o2h Ventures' business model combines access to opportunities similar to China's Wuxi Ventures with an incubation approach akin to USA's Atlas Ventures, aiming to improve the prospects of successful exits. o2h Ventures emphasizes early involvement with founders, providing not only capital but also co-working lab and office space, hands-on scientific input, and ongoing board-level mentorship and strategic support. This integrated approach aims to help companies focus on innovation and rapid development. They also provide support through their research services company, o2h Discovery. The firm's investment strategy is knowledge-intensive, focusing on areas where they have deep expertise and can provide significant value beyond just capital.
rule30
Rule30 is an AI research lab and venture fund focused on re-engineering venture capital using technology and systematic strategies. They aim to deliver precision, repeatable performance, and scale by applying a fully algorithmic approach to identify and back outlier founders at scale. Their decision engine probabilistically ranks early-stage founders, identifying the top 10%, 3%, and 0.1%. They are creating a new category in venture: algorithmically curated outlier founders. The firm builds the decision engine and systematically deploys it in the market via an index-style strategy.
Adjuvo
Adjuvo is a network and investment syndicate of experienced investors who invest in and support innovative, high-growth, early-stage British companies. Their model for success revolves around 'Excellence' in invested companies and founders, 'Expertise' of their members, network and partners, and 'Execution' of their constructive capitalism strategy, with the concept of 'I help' at its core. They seek entrepreneurial founders with exemplary vision and the talent and resources to execute in sizeable markets. While sector-agnostic, Adjuvo members tend to avoid capital-intensive businesses and highly regulated areas, preferring platforms, software, disrupters, and consumer-facing businesses with proven and patented USPs. Adjuvo's investment strategy centers on identifying and supporting British early-stage companies where EIS relief is available. They aim to assist these companies in maximizing their potential by drawing on the combined expertise of their 200+ members. They look for brands with outstanding founders and contemporary relevance. The firm's focus on constructive capitalism emphasizes not only financial returns but also job creation and positive societal impact. The firm provides value beyond capital by leveraging the extensive experience and expertise of its members. Members are encouraged to actively participate in the portfolio companies, offering mentorship, strategic advice, commercial introductions, and sometimes taking on non-executive board roles. This active involvement aims to accelerate growth and maximize the potential of each investment. Adjuvo's network effect provides portfolio companies with access to a vast pool of knowledge and resources. With members spanning diverse industries and senior roles, the portfolio companies gain access to insights and connections that would otherwise be difficult to obtain. This network is a core strength of Adjuvo and a key differentiator.
Ahren Innovation Capital
Ahren Innovation Capital focuses on investing in deep technology companies that are at the intersection of groundbreaking science and high-end technology. Their investment strategy is geared towards creating outsized returns while also having a positive impact on the world. They back founders with big visions and provide support to help them achieve their goals. They believe in taking asymmetric, considered risks to capture generational opportunities in deep technology. Ahren partners with stellar founders and teams at all stages from pre-seed to pre-IPO, and are willing to help build companies from scratch or provide capital and expertise to high-growth businesses. Their approach involves deep tech expertise from their Founding & Science Partners, who have created technologies with a combined value of over $100BN. They are involved throughout the investment process, from sourcing to deep-tech diligence, and supporting businesses. They offer a Commercial Engine and Unicorn Founder advisors to help their companies achieve success. They also value strategic LP partnerships, where major LPs provide access, expertise, and customers to their portfolio companies. Ahren prioritizes strong values and treating founders well, aiming to be a trusted and respected group that can have a differentiated impact on their success. They aim to add value to exceptional founders at any stage, providing both patient and active capital to empower them to achieve the unimaginable.
Albion VC
AlbionVC aims to support visionary founders with long-term capital and scale-up expertise, leveraging their know-how since 1996. They focus on early-stage software, healthcare, and deeptech companies, acting as partners to entrepreneurs throughout their journey. The firm's strategy involves identifying and investing in companies with high growth potential in these sectors, providing not only financial support but also strategic guidance and operational expertise to help them scale and succeed. AlbionVC also emphasizes its long track record and extensive network, positioning itself as a valuable partner for founders looking to build impactful and sustainable businesses. AlbionVC provides support in building the company and has a platform and talent arm.
AlbionVC
AlbionVC supports visionary founders with long-term capital and scale-up expertise, drawing on experience since 1996. They aim to help founders succeed by providing not just capital but also valuable know-how. They focus on early-stage software, healthcare, and deeptech companies. The firm seems to emphasize partnership and providing support beyond just funding, with a focus on helping companies build and scale. They look for founders who value efficiency, positivity, and empathy.
Amadeus Capital Partners
Amadeus Capital Partners focuses on deep tech investments across AI, quantum computing, health, sustainability, materials, and space. With a track record of over 200 portfolio companies and $1.3B+ in capital raised, the firm targets transformative technologies that drive intelligence, human well-being, and planetary sustainability.
Augmentum
Augmentum is Europe's leading publicly listed fintech fund, focused on backing category-leading European fintechs in their early stages. They provide patient capital, industry expertise, and network access to drive growth and innovation in the fintech sector. Their investment strategy centers around identifying and supporting exceptional fintech teams, partnering closely to accelerate their growth and provide specialist advice and connections, including regulators, policymakers, talent, and incumbents. Augmentum leverages the extensive fintech investment experience of its partners, who have invested in 100+ fintechs over 16 years, and a well-networked team of entrepreneurs and investors who have been on both sides of the fence. They aim to be a true partner, supporting companies from initial investment through to exit. The firm adds value by providing entrepreneurial DNA, bringing their experience as former builders of fintech businesses to help portfolio companies navigate the challenges of scaling at pace. They also offer support in future fundraising, from pitch advice to investor introductions. Augmentum's deep network across the fintech sector enables them to open doors for portfolio companies, aiding in talent acquisition, business development, and future fundraising rounds. Augmentum's evergreen structure allows for flexibility and meaningful follow-on investments, demonstrating their commitment to long-term partnerships with their portfolio companies.
Augmentum Fintech
Augmentum specializes in backing category-leading European fintech companies, leveraging over 70 years of collective fintech investment experience. They provide patient capital, industry expertise, regulatory/policy connections, and a deep network to drive growth and innovation. The firm emphasizes hands-on support, long-term partnerships, and access to talent, business development, and fundraising opportunities.
Bessemer Venture Partners
Bessemer Venture Partners focuses on partnering with entrepreneurs from their early days through every stage of growth. Their investment approach appears to be sector-agnostic but demonstrates a strong emphasis on identifying and supporting companies building enduring businesses. This is evidenced by their extensive portfolio and history of over 150 IPOs/deSPACs. A significant aspect of their strategy involves providing resources and insights through their 'Atlas' platform, offering roadmaps, benchmarks, and guidance on company building. They prioritize providing value to their portfolio companies beyond just capital, aiming to contribute to their long-term success and market leadership.
Brighteye Advisors London Limited
Brighteye Ventures focuses on backing founders who are shaping what they call the 'HumanOS' - enabling people to learn, work, and adapt. They believe technology is a powerful lever, and as software becomes more intelligent and autonomous, it enhances the value of human skills, knowledge, and talent. The firm aims to partner early with founders building systems that redefine human capabilities in these areas. They are particularly interested in companies that are harnessing technology to redefine human capability. Their investment thesis revolves around identifying and supporting the next generation of category-defining companies that are leveraging technology to improve and enhance human potential. This encompasses systems and tools that facilitate continuous learning, improve work processes, and enable people to adapt to evolving environments. Brighteye Ventures seeks to partner with founders at the early stages of their journey to build these transformative systems. They express a deep care for the founders they back, offering support from early insights to late-night calls. They bring craft, deep sector expertise, and an international network built to help founders grow. Brighteye operates with a founder-first mentality. Recognizing that founders are the heart of their investments, they aim to provide support and guidance that go beyond just capital. This commitment is reflected in their stated dedication to being available and supportive throughout the founder's journey. They show up with craft, deep sector expertise, and an international network built to help you grow. They emphasize people are at the heart of everything they do, and that they are deeply committed to the founders they back.
Cambridge Innovation Capital
Cambridge Innovation Capital (CIC) focuses on investing in knowledge-intensive businesses, specifically in life sciences and deep tech, within the Cambridge ecosystem. Their investment strategy centers on identifying and supporting entrepreneurs with groundbreaking ideas that have the potential to transform lives and achieve global impact. CIC leverages its unique relationship with the University of Cambridge and its network of entrepreneurs, research institutes, and accelerators to gain early access to promising startups. They aim to provide financial backing and expert guidance to enable these pioneers to build world-leading companies. CIC aims to be a leading Series A investor, capitalizing on its privileged access to the University of Cambridge's innovative ideas and talent. They are driven by a passion for science and its ability to drive change. The firm seeks to invest in companies with the potential for both financial success and positive societal impact. They believe that prioritizing impact and ESG (Environmental, Social, and Governance) factors will enhance long-term financial returns. Their approach includes actively engaging with portfolio companies to incorporate ESG principles into their operations. CIC demonstrates leadership by working with partners in the innovation ecosystem to accelerate the integration of impact and ESG considerations. They have a dedicated Responsible Investment report which highlights their progress, learnings, and the link between ESG and value creation within their portfolio. Ultimately, Cambridge Innovation Capital aims to foster innovation and create a positive impact by investing in and supporting companies that are developing cutting-edge technologies and solutions in life sciences and deep tech. They emphasize a combination of scientific knowledge, commercial expertise, and a commitment to sustainability.
CircleRock Capital
CircleRock Capital operates as a venture capital syndicate, focusing on providing access to early-stage investments alongside top-tier global VCs for a network of investors. Their approach enables individuals, family offices, exited entrepreneurs, venture-backed founders, and leaders from top tech companies to participate in curated deal flow typically inaccessible to private investors. CircleRock differentiates itself by offering deal-by-deal investment opportunities, cheaper fees than traditional funds (one-off instead of recurring), and the chance to build a diversified portfolio based on individual interests and risk appetites. They focus on investing alongside established VCs, providing retail investors access to deals that otherwise would be unavailable.